-
1
المؤلفون: Roberto Diaz-Beveridge, Luis Miguel De Sande-González, Antonio López Pousa, Jordi Rubió-Casadevall, Javier Martin-Broto, Pablo Luna, Juan Antonio Carrasco, Claudia M Valverde-Morales, Andres Poveda, Gloria Marquina, María Ángeles Vaz Salgado, Javier Martinez-Trufero, Antonio Gutierrez, Ana De Juan, Juana María Cano, Ibon Gurruchaga-Sotes, Isabel Sevilla, Josefina Cruz-Jurado, Jerónimo Martínez-García, Rosa Alvarez, David S. Moura
المساهمون: Institut Català de la Salut, [Martínez-Trufero J] Javier Martinez-Trufero, Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. [De Sande-González LM] Medical Oncology Department, Complejo Asistencial Universitario de Leon, Leon, Spain. [Luna P] Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain. [Martin-Broto J] Medical Oncology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBiS, CSIC, US, HUVR), Sevilla, Spain. [Álvarez R] Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain. [Marquina G] Medical Oncology Department, Hospital Universitario Clinico San Carlos, Madrid, Spain. [Valverde-Morales CM] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, [Martínez-Trufero,J, Gurruchaga-Sotes,I] Javier Martinez-Trufero, Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. [De Sande-González,LM] Medical Oncology Department, Complejo Asistencial Universitario de Leon, Leon, Spain. [Luna,P] Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain. [Martin-Broto,J] Medical Oncology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBiS, CSIC, US, HUVR), Sevilla, Spain. [Álvarez,R] Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain. [Marquina,G] Medical Oncology Department, Hospital Universitario Clinico San Carlos, Madrid, Spain. [Diaz-Beveridge,R] Medical Oncology Department, Hospital Politécnico La Fe, Valencia, Spain. [Poveda,A] Medical Oncology Department, Instituto Valenciano de Oncologia, Valencia, Spain. [Cano,JM] Medical Oncology Department, Hospital General de Ciudad Real, Ciudad Real, Spain. [Cruz-Jurado,J] Medical Oncology Department, Hospital Universitario Canarias, Santa Cruz de Tenerife, Spain. [López Pousa,A] Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain. [Vaz Salgado,MA] Medical Oncology Department, Hospital Universitario Ramon y Cajal, RYCIS, CIBERONC, Madrid, Spain. [Valverde-Morales,C] Medical Oncology Department, Hospital Universitario Vall D’Hebron, Barcelona, Spain. [Sevilla,I] Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Medical Oncology Department, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Malaga, Spain. [Martínez-García,J] Medical Oncology Department, Hospital Virgen de la Arrixaca, Murcia, Spain. [Rubio-Casadevall,J] Medical Oncology Department, Instituto Catalan Oncologia, Girona, Spain. [De Juan,A] Medical Oncology Department, Hospital Marqués de Valdecilla, Santander, Spain. [Carrasco,JA] Medical Oncology Department, Hospital Alvaro Cunqueiro, Vigo, Spain. [Moura,DS] Instituto de Biomedicina de Sevilla (IBiS, CSIC, US, HUVR), Sevilla, Spain. [Gutiérrez,A] Hematology Department, Hospital Universitario Son Espases, 07010 Palma de Mallorca, Spain., This research was funded by the Spanish Group for Research on Sarcoma (grant number: NA) and partially by PharmaMar. PharmaMar S.A. did not have any role in study design, or in collection, analysis and interpretation of data.
المصدر: Cancers
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancers, Vol 13, Iss 792, p 792 (2021)
Scientia
Volume 13
Issue 4
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauمصطلحات موضوعية: 0301 basic medicine, Oncology, Advanced soft tissue sarcomas, Cancer Research, Multivariate analysis, sarcoma, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies [Medical Subject Headings], Trabectedina, España, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma [Medical Subject Headings], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Metastasis, Prognostic score, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, Trabectedin, Tumors de parts toves, Soft tissue sarcoma, Pronóstico, Soft tissue, Liposarcoma, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, prognostic score, GEISTRA, L-sarcoma, growth modulation index, prognostic score, sarcoma, trabectedin, 030220 oncology & carcinogenesis, trabectedin, Sarcoma, L-sarcoma, medicine.drug, medicine.medical_specialty, Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Thiazoles::Thiamine::Thiamine Triphosphate [Medical Subject Headings], GEISTRA, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Analysis of Variance::Multivariate Analysis [Medical Subject Headings], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms [DISEASES], epidemiología y bioestadística::epidemiología::usos de la epidemiología::efectividad [SALUD PÚBLICA], lcsh:RC254-282, Article, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma::Leiomyosarcoma [Medical Subject Headings], 03 medical and health sciences, Internal medicine, medicine, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma::Liposarcoma [Medical Subject Headings], neoplasias::neoplasias por localización::neoplasias de los tejidos blandos [ENFERMEDADES], Geographical Locations::Geographic Locations::Europe::Spain [Medical Subject Headings], business.industry, Retrospective cohort study, medicine.disease, 030104 developmental biology, Spain, Medicaments - Eficàcia, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings], Epidemiology and Biostatistics::Epidemiology::Uses of Epidemiology::Effectiveness [PUBLIC HEALTH], Leiomiosarcoma, business, growth modulation index
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ae189020c1b9820dc01b3e6d0041c2Test
https://hdl.handle.net/10668/17307Test -
2
المؤلفون: Begoña Olmedilla-Alonso, Maria Hernandez, Alfredo García-Layana, Miguel A Zapata, Sergio Recalde, Maximino Abraldes, João Nascimento, Jose Juan Escobar-Barranco, M.C. López-Sabater, Silvia Mendez-Martinez, Rufino Silva, Pilar Calvo, Mariana Caballero Arredondo, Nieves Pardiñas-Barón, Patricia Fernandez-Robredo, Emiliano Hernández-Galilea
المساهمون: Institut Català de la Salut, [García-Layana A, Recalde S, Hernandez M] Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain. Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain. Red Temática de Investigación Cooperativa Sanitaria en Enfer-Medades Oculares (Oftared), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Abraldes MJ] Red Temática de Investigación Cooperativa Sanitaria en Enfer-Medades Oculares (Oftared), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Nascimento J] Retinal Department, Ophthalmology, Retina Lisbon Institut, 1050-085 Lisbon, Portugal. [Hernández-Galilea E] Department of Ophthalmology, University of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain. [Zapata MA] Servei d’Oftalmologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Laboratoires Théa, European Commission, Instituto de Salud Carlos III
المصدر: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Scientia
Nutrients, Vol 13, Iss 1253, p 1253 (2021)
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
Nutrients
Volume 13
Issue 4مصطلحات موضوعية: 0301 basic medicine, Male, Lutein, Visual acuity, Eye disease, Visual Acuity, Xanthophylls, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Gastroenterology, law.invention, Retilut®, chemistry.chemical_compound, Macular Degeneration, 0302 clinical medicine, Randomized controlled trial, law, chemistry.chemical_classification, Aged, 80 and over, Nutrition and Dietetics, carotenoids, food and beverages, Diabetic retinopathy, Middle Aged, Phenylethyl Alcohol, inflammatory markers, Zeaxanthin, Treatment Outcome, Female, medicine.symptom, lcsh:Nutrition. Foods and food supply, Polyunsaturated fatty acid, polyunsaturated fatty acids, medicine.medical_specialty, Nutritional Supplementation, Docosahexaenoic Acids, Eye Diseases::Retinal Diseases::Retinal Degeneration::Macular Degeneration [DISEASES], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], lcsh:TX341-641, Article, Theavit®, 03 medical and health sciences, Zeaxanthins, Internal medicine, medicine, Humans, age-related macular degeneration, Aged, business.industry, Age-related macular degeneration, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Nutrients, medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Carotenoids, eye diseases, oftalmopatías::enfermedades de la retina::degeneración retiniana::degeneración macular [ENFERMEDADES], 030104 developmental biology, AREDS, chemistry, Resveratrol, Dietary Supplements, 030221 ophthalmology & optometry, angiogenic factors at month 12, Medicaments - Eficàcia, Avaluació de resultats (Assistència sanitària), Degeneració macular - Tractament, business, Food Science
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900fd947ba5d8f723e658c77a5a301c0Test
http://zaguan.unizar.es/record/118791Test -
3
المؤلفون: Lorena Fariñas-Madrid, Angel Guerrero-Zotano, Raquel López-Reig, Pedro Mallol, Victor Rodriguez-Freixinos, Ana Oaknin, Andres Poveda, Ignacio A. Romero, José Antonio López-Guerrero
المساهمون: Institut Català de la Salut, [Poveda A] Oncogynecologic Department, Initia Oncology, Hospital Quironsalud Valencia, Avda Blasco Ibañez, 14, 46 010 Valencia, Spain. [Oaknin A, Fariñas-Madrid L] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Romero I, Guerrero-Zotano A] Department of Medical Oncology, Fundación Instituto Valenciano de Oncología (IVO), Valencia, Spain. [Rodriguez-Freixinos V] Department of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientific Reports
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
instname
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientiaمصطلحات موضوعية: 0301 basic medicine, Oncology, Molecular biology, Piperazines, Medicaments antineoplàstics, chemistry.chemical_compound, 0302 clinical medicine, Neoplasms, terapéutica::farmacoterapia::farmacoterapia combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Càncer, Cancer, Multidisciplinary, Therapeutics::Drug Therapy::Drug Therapy, Combination [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Middle Aged, 030220 oncology & carcinogenesis, Vomiting, Medicine, medicine.symptom, medicine.medical_specialty, Genotype, Maximum Tolerated Dose, Nausea, Anemia, Science, Neutropenia, Poly(ADP-ribose) Polymerase Inhibitors, Heterocyclic Compounds, 4 or More Rings, Article, Olaparib, neoplasias [ENFERMEDADES], 03 medical and health sciences, Breast cancer, Medical research, Pharmacokinetics, Internal medicine, medicine, Humans, Adverse effect, Aged, business.industry, medicine.disease, Physiological Phenomena::Pharmacological and Toxicological Phenomena::Pharmacological Phenomena::Dose-Response Relationship, Drug [PHENOMENA AND PROCESSES], Neoplasms [DISEASES], 030104 developmental biology, chemistry, Medicaments - Eficàcia, fenómenos fisiológicos::fenómenos farmacológicos y toxicológicos::fenómenos farmacológicos::relación dosis-respuesta de medicamentos [FENÓMENOS Y PROCESOS], Phthalazines, business, Carbolines
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a11dd091df1dfd415fa0f313d9b3f47Test
https://pubmed.ncbi.nlm.nih.gov/33627685Test